Use of GLP-1 receptor drugs and mental health in teenagers with obesity: a look back study

Adolescent obesity is associated with increased rates of depression and suicidality.

• GLP-1 receptor agonists are being used to treat pediatric obesity.
• Concerns exist about the potential psychiatric effects of GLP-1 receptor agonists.
• The study focuses on evaluating changes in depressive symptoms and suicidality in adolescents receiving GLP-1RA therapy.
• Changes in depressive symptoms and suicidality screening scores were assessed following treatment initiation.

Simplified